Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic studyBen Van Calster, Kirsten Van Hoorde, L. Valentin et al.|BMJ|2014Cited by 500
Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA groupD. Timmerman, L. Valentin, Lieveke Ameye et al.|BMJ|2010Cited by 473
Predicting the risk of malignancy in adnexal masses based on the Simple Rules from the International Ovarian Tumor Analysis groupD. Timmerman, L. Valentin, Ben Van Calster et al.|American Journal of Obstetrics and Gynecology|2016Cited by 329
ESGO–ESMO–ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent diseaseJonathan A. Ledermann, Anna Fagotti, C.A.R. Lok et al.|Annals of Oncology|2024Cited by 277
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice GuidelineCristiana Sessa, Shani Paluch–Shimon, Judith Balmañà et al.|Annals of Oncology|2022Cited by 271